Skip to main content

FORMULACION DE PRODUCTOS ALIMENTARIOS PARA LA PREVENCION Y EL TRATAMIENTO DIRIGIDO DE ENFERMEDADES CRONICAS RELACIONADAS CON EL METABOLISMO.

AGL2016-76736-C3-3-R

•
Funding agency name Agencia Estatal de Investigación
Funding agency acronym AEI
Program Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Call Proyectos I+D+i Retos de Investigación
Call year 2016
State Plan 2013-2016 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre FUNDACION IMDEA NUTRICIÓN

Resultados relacionados

Resultados totales (Incluyendo duplicados): 4
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Novel polyphenols that inhibit colon cancer cell growth affecting cancer cell metabolisms

  • Gómez de Cedrón, Marta
  • Vargas, Teodoro
  • Madrona, Andrés
  • Jiménez, Aranza
  • Peréz-Pérez, María-Jesús
  • Quintela, José Carlos
  • Reglero, Guillermo
  • San-Félix, Ana
  • Ramírez de Molina, Ana
New series of polyphenols with a hydrophilic galloyl-based head and a hydrophobic N-acyl tail, linked through a serinol moiety, have been synthesized and tested against colon cancer cell growth. Our structure activity relationship studies revealed that galloyl moieties are essential for growth inhibition. Moreover, the length of the N-acyl chain is crucial for the activity. Introduction of a (Z) double bond in the acyl chain increased the anticancer properties. Our findings demonstrate that 16, the most potent compound within this series, has inhibitory effects on colon cancer cell growth and metabolism (glycolysis and mitochondrial respiration) at the same time that it activates 59AMP-activated kinase (AMPK) and induces apoptotic cell death. Based on these results, we propose that 16 might reprogram colon cancer cell metabolism through AMPK activation. This might lead to alterations on cancer cell bioenergy compromising cancer cell viability. Importantly, these antiproliferative and proapoptotic effects are selective for cancer cells. Accordingly, these results indicate that 16, with an unsaturated C18 chain, might be a useful prototype for the development of novel colon cancer cell growth inhibitors affecting cell metabolism., This work was supported by the Spanish Plan Nacional de Cooperación Público-Privada, Subprograma INNPACTO (IPT-2012-0213 060000, cofinanced by the FEDER program); the Spanish MINECO [Project SAF2015-64629-C2-1-R (MINECO/FEDER)]; AGL2016-76736-C3-3-R (MINECO/FEDER); and Regional government Comunidad de Madrid (P2013/ABI-2728, ALIBIRD-CM) and European Union Structural Funds. The European Social Fund (Youth Employment Operational Program 2014-2020) supports a contract in practices (to A.J.)., Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Contribución de congreso (ConferenceOutput)

Marigold supercritical extracts as a potencial anticancer agent

  • Mouhid, Lamia
  • Gómez de Cedrón, Marta
  • García-Risco, Mónica R.
  • Reglero, Guillermo
  • Fornari, Tiziana
  • Ramírez de Molina, Ana
Resumen del trabajo presentado a las III Jornadas Científicas CIAL Fórum, celebradas del 22 al 23 de noviembre de 2018 en el Instituto de Investigación en Ciencias de la Alimentación (CIAL)., Calendula officinalis, commonly known as marigold, has been used in traditional medicine for its anti-inflammatory and antiseptic virtues, and against gastric spasms. Here, we had obtained marigold extracts through supercritical CO2 extraction (SFE) and through ultrasonic assisted extraction (UAE), and we had characterized their bioactivity in the framework of cancer. We have found that marigold UAE extracts have a higher content of phenolic and flavonoid than marigold SFE extract, as well as a higher antioxidant activity. On the contrary, marigold SFE extract has a stronger cytotoxic and antiproliferative activity against pancreatic tumor-derived cells, being independent to its antioxidant effect. These results suggest that marigold SFE could be considered for further studies as a potential nutritional supplement which could improve current cancer therapies., This work has been supported by the Spanish MINECO (AGL2016-76736-C3-3-R MINECO/FEDER), Regional government Comunidad de Madrid (P2013/ABI-2728, ALIBIRD-CM) and EU Structural Funds., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Contribución de congreso (ConferenceOutput)

Effect of yarrow supercritical extract as a novel approach to pancreatic cancer treatment

  • Mouhid, Lamia
  • Gómez de Cedrón, Marta
  • Reglero, Guillermo
  • Fornari, Tiziana
  • Ramírez de Molina, Ana
Trabajo presentado a la IX Reunión de Expertos en Tecnologías de Fluidos Comprimidos (Flucomp), celebrada en el Campus UAM Cantoblanco (Madrid) del 13 al 15 junio 2018., Pancreatic cancer is one of the most aggressive tumors which occurrence is linked, together with genetic factors, to diet and lifestyle. Trying to potentiate the use of natural derived products from diet, here we propose a supercritical extract (SFE) as a nutritional supplement for cancer treatment. Yarrow SFE has demonstrated to be cytotoxic for pancreatic cancer cells (MIA PaCa-2), and able to brake 3D-sphere growth. In addition, it causes cell death through caspase 3/7 activation and therefore, triggering apoptosis. Moreover, treating MIA PaCa-2 with a chemotherapeutical agent used in clinic (5-Fluorouracil) after sensitizing them with Yarrow SFE has shown a synergetic effect between both. Finally, in a xenograft model, it has shown that animals who received Yarrow SFE extract develop a smaller tumor. In summary, our results indicate that Yarrow supercritical extract is a promising antitumoral co-adjuvant in pancreatic cancer treatment., L. Mouhid acknowledges the predoctoral contract given by IMDEA Food Institute, Spain. This work has been supported by the Spanish MINECO (AGL2016-76736-C3-3- R MINECO/FEDER), Regional government Comunidad de Madrid (P2013/ABI- 2728, ALIBIRD-CM) and EU Structural Funds., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Precision nutrition and cancer relapse prevention: A systematic literature review

  • Reglero, Clara
  • Reglero, Guillermo
This article belongs to the Special Issue Dietary Patterns, Dietary Indices for Colorectal Cancer, Mortality and the Related Disease., Cancer mortality rates are undergoing a global downward trend; however, metastasis and relapse after surgery and adjuvant treatments still correlate with poor prognosis and represent the most significant challenges in the treatment of this disease. Advances in genomics, metabolomics, and proteomics are improving our understanding regarding cancer metabolic diversity, resulting in detailed classifications of tumors and raising the effectiveness of precision medicine. Likewise, the growing knowledge of interactions between nutrients and the expression of certain genes could lead to cancer therapies based on precision nutrition strategies. This review aims to identify the recent advances in the knowledge of the mechanistic role of bioactive phytochemicals in foodstuffs in tumor progression, metastasis, and chemo-resistance in order to assess their potential use in precision nutrition therapies targeting relapse in lung, breast, colon, and prostate cancer, and leukemia. A considerable number of bioactive phytochemicals in foodstuffs were identified in the literature with proven effects modulating tumor growth, progression, and metastasis. In addition, the use of foodstuffs in cancer, and specifically in relapse therapies, is being reinforced by the development of different formulations that significantly increase the therapeutic efficiency of these products. This can open the possibility for testing combinations of bioactive phytochemicals with cancer relapse treatments as a potential prevention strategy., This research is part of the work plan of Project AGL2016-76736-C3 supported by the Spanish Ministerio de Ciencia, Innovación y Universidades; Project P2018/BAA-4343-ALIBIRD2020-CM supported by the Regional Government of Comunidad de Madrid (V PRICYT)., Peer reviewed